Actinium Pharmaceuticals, Inc. (Delaware) (ATNM) SEC filings
ATNM SEC filings moved a median of +0.76% by the close. ATNM SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ATNM overview →
34 measured ATNM SEC filing events.
Where these ATNM SEC filings landedvs 32 measured ATNM SEC filing reactions
| Middle 50% of ATNM SEC filing reactions | -5.22% to +3.40% |
|---|---|
| Median reaction (to close) | +0.76% |
| Measured reactions | 32 |
Point-in-time · zero look-ahead
Half of the 32 ATNM SEC filing events with a measured close landed between -5.22% and +3.40%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Actinium Pharmaceuticals For: Oct 14 | SEC filing · Form 8-K | — | — | |
| Form S-8 Actinium Pharmaceuticals | SEC filing · Form S-8 | +0.00% | -2.75% | |
| Form 8-K Actinium Pharmaceuticals For: Aug 12 | SEC filing · Form 8-K | -0.90% | -5.41% | |
| Form 10-Q Actinium Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +0.00% | — | |
| Form 8-K Actinium Pharmaceuticals For: Jun 18 | SEC filing · Form 8-K | +0.00% | +0.98% | |
| Form 8-K Actinium Pharmaceuticals For: May 27 | SEC filing · Form 8-K | -1.59% | -6.35% | |
| Form 10-Q Actinium Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -1.67% | +1.51% | |
| Form 10-K Actinium Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.54% | |
| Form 8-K/A Actinium Pharmaceuticals For: Nov 26 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Actinium Pharmaceuticals For: Feb 11 | SEC filing · Form 8-K | +0.43% | -6.09% | |
| Form 8-K Actinium Pharmaceuticals For: Nov 26 | SEC filing · Form 8-K | -0.99% | -4.17% | |
| Form 10-Q Actinium Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +5.07% | |
| Form ARS Actinium Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | -0.73% | -2.94% | |
| Form DEF 14A Actinium Pharmaceuticals For: Nov 26 | SEC filing · Form DEF | -0.73% | -2.94% | |
| Form 10-Q Actinium Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -1.84% | -5.16% | |
| Form 10-Q Actinium Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +3.33% | +3.33% | |
| Form 8-K Actinium Pharmaceuticals For: May 08 | SEC filing · Form 8-K | +3.33% | +3.33% | |
| Form 10-K Actinium Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.31% | -6.88% | |
| Form 8-K Actinium Pharmaceuticals For: Nov 27 | SEC filing · Form 8-K | +2.16% | +3.60% | |
| Form 10-Q Actinium Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +1.17% | -9.64% | |
| Form ARS Actinium Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | -3.04% | +1.05% | |
| Form 8-K Actinium Pharmaceuticals For: Nov 01 | SEC filing · Form 8-K | -3.04% | +1.05% | |
| Form DEF 14A Actinium Pharmaceuticals For: Nov 27 | SEC filing · Form DEF | -3.04% | +1.05% | |
| Form 10-Q Actinium Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +18.18% | +21.61% | |
| Form 8-K Actinium Pharmaceuticals For: Aug 05 | SEC filing · Form 8-K | -13.45% | +45.03% | |
| Form 10-Q Actinium Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +1.45% | +6.96% | |
| Form 10-K Actinium Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +5.98% | +9.32% | |
| Form S-8 Actinium Pharmaceuticals | SEC filing · Form S-8 | +5.98% | +9.32% | |
| Form EFFECT Actinium Pharmaceuticals | SEC filing · Form EFFECT | +1.55% | +2.72% | |
| Form S-3/A Actinium Pharmaceuticals | SEC filing · Form S-3 | -1.33% | -1.90% | |
| Form 8-K Actinium Pharmaceuticals For: Nov 30 | SEC filing · Form 8-K | +4.13% | +10.32% | |
| Form ARS Actinium Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | -0.43% | -5.57% | |
| Form DEF 14A Actinium Pharmaceuticals For: Nov 30 | SEC filing · Form DEF | -0.43% | -5.57% | |
| Form 10-Q Actinium Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +2.00% | -16.58% |
Keep exploring
More ATNM: earnings → · analyst actions → · ATNM overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Second Sight Medical Products, Inc. (EYES) | 788 | -0.56% | 34% |
| bluebird bio, Inc. (BLUE) | 787 | -0.01% | 46% |
| Heat Biologics, Inc. (HTBX) | 781 | -0.40% | 41% |
| HEMISPHERX BIOPHARMA (HEB) | 779 | -0.06% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.